Curriculum Vitaes
Profile Information
- Affiliation
- School of Medicine Faculty of Medicine, Fujita Health University
- J-GLOBAL ID
- 201701017629350587
- researchmap Member ID
- 7000019943
Research Areas
1Papers
132-
International archives of allergy and immunology, 1-14, Jul 20, 2023INTRODUCTION: Screening for ω-5 gliadin specific IgE antibody (sIgE) has high diagnostic utility in cases of suspected wheat-dependent exercise-induced anaphylaxis (WDEIA); however, negative cases may require confirmatory tests, such as the oral challenge test. Thus, newly identified allergens that can be used for the serological diagnosis of WDEIA are needed. This study aimed to identify additional sIgE biomarkers of WDEIA. METHODS: Forty-two patients with WDEIA (5 negative/37 positive for ω-5 gliadin sIgE) were enrolled. For comparison, 8 patients with immediate-type wheat allergy without WDEIA and 20 healthy controls without wheat allergy were also enrolled. Extracted wheat proteins were separated by 2D-PAGE. Proteins that reacted with serum IgE antibody in 2D Western blotting (2D-WB) were identified using mass spectrometry. Recombinant proteins were synthesized in Escherichia coli, and the antigenicity was tested using ELISA and the basophil activation test. RESULTS: In 2D-WB, nine proteins reacted with the serum IgE antibody from at least 60% of patients with WDEIA (n ≥ 25/42). ELISA revealed that alpha/beta gliadin MM1 exhibited the highest positive immunoreactivity in 23 of 26 patients who were positive for ω-5 gliadin sIgE (88%) and in 5 of 5 patients who were negative for ω-5 gliadin sIgE (100%). Alpha/beta gliadin MM1 exhibited significantly higher basophil activation in 14 patients with WDEIA when compared to 5 individuals without a wheat allergy. CONCLUSIONS: Alpha/beta gliadin MM1 sIgE exhibited the highest seropositivity, even among patients who were negative for ω-5 gliadin sIgE. The inclusion of alpha/beta gliadin MM1 in allergen-sIgE tests may improve the sensitivity for diagnosing WDEIA.
-
Allergology international : official journal of the Japanese Society of Allergology, 72(2) 279-285, Dec 12, 2022BACKGROUND: Immediate allergy caused by natto, a popular Japanese food prepared by fermenting soybeans with Bacillus subtilis var. natto, has been reported. Polygamma glutamic acid (PGA) in the sticky substance around natto beans has been reported to be a causative allergen of natto allergy. However, some of our patients with natto allergy were negative for PGA in the skin prick test (SPT). The sticky substance of natto beans contains a subtilisin family serine protease, nattokinase, along with PGA. In this study, we aimed to examine the antigenicity of nattokinase in natto allergy. METHODS: Eight patients, who developed symptoms after ingesting natto and positively reacted to natto (seven to the sticky substance in natto and one to the whole natto product) in their SPT, were enrolled in this study. To analyze IgE reactivity, we performed immunoblotting, ELISA, and SPT for natto (bean and sticky substance), and/or PGA, and/or nattokinase and/or cultured B. subtilis var. natto extract. RESULTS: In the SPT, four cases each were PGA-positive and PGA-negative. Immunoblotting of the sera from PGA-negative patients showed a protein band at 30 kDa, which was identified as nattokinase. Three PGA-negative cases, but not three PGA-positive cases, showed a positive reaction to nattokinase in the SPT and had a history of atopic dermatitis. The ELISA for nattokinase revealed a positive reaction of PGA-negative cases and negative reaction of PGA-positive cases in the SPT. CONCLUSIONS: We identified a subtilisin family serine protease, nattokinase, as a novel allergen in natto allergy patients unsensitized to PGA.
-
Seven cases of allergic contact dermatitis caused by cosmetics containing 3-O-ethyl-L-ascorbic acid.Contact dermatitis, 86(5) 421-423, May, 2022
-
Contact dermatitis, 87(1) 108-110, Mar 20, 2022
-
Contact dermatitis, 86(3) 189-195, Mar, 2022BACKGROUND: The Japanese baseline series (JBS), established in 1994, was updated in 2008 and 2015. The JBS 2015 is a modification of the thin-layer rapid-use epicutaneous (TRUE) test (SmartPractice Denmark, Hillerød, Denmark). No nationwide studies concerning the TRUE test have previously been reported. OBJECTIVES: To determine the prevalence of sensitizations to JBS 2015 allergens from 2015 to 2018. METHODS: We investigated JBS 2015 patch test results using the web-registered Skin Safety Care Information Network (SSCI-Net) from April 2015 to March 2019. RESULTS: Patch test results of 5865 patients were registered from 63 facilities. The five allergens with the highest positivity rates were gold sodium thiosulfate (GST; 25.7%), nickel sulfate (24.5%), urushiol (9.1%), p-phenylenediamine (PPD; 8.9%), and cobalt chloride (8.4%). The five allergens with the lowest positivity rates were mercaptobenzothiazole (0.8%), formaldehyde (0.9%), paraben mix (1.1%), mercapto mix (1.1%), and PPD black rubber mix (1.4%). CONCLUSIONS: Nickel sulfate and GST had the highest positivity rates. The JBS 2015, including a modified TRUE test, is suitable for baseline series patch testing.
Misc.
189-
Skin Cancer, 26(2) 210-214, Sep, 2011 Peer-reviewedA 78-year-old man was referred to our department via the Department of Surgery at our hospital due to a recurrent thyroid tumor. He had undergone surgery for thyroid cancer at another hospital 15 years earlier, and resection of a local recurrence 12 years ago. He had received a total of 85 Gy of radiation for two other local tumor recurrences, 11 and 5 years ago respectively. He had been referred to the Department of Surgery due to a subsequent increase in tumor size as well as an increase in bleeding from 1 year ago.<br>A hemorrhagic and malodorous mass was observed on the right side of the anterior neck region on initial examination. As the tumor was highly hemorrhagic, embolization of the right superior thyroid artery was performed four times, and Mohs chemosurgery was performed to stop the bleeding from the tumor surface and to reduce the tumor size. Mohs chemosurgery reduced the amount of bleeding from the tumor region as well as the tumor size, results which improved the patient's quality of life (QOL).[Skin Cancer (Japan) 2011 ; 26 : 210-214]
-
Journal of Environmental Dermatology and Cutaneous Allergology, 35(3) 324-324, Sep, 2011 Peer-reviewed
-
Journal of Environmental Dermatology and Cutaneous Allergology, 5(3) 324-324, Jul, 2011
-
Journal of Environmental Dermatology and Cutaneous Allergology, 15(1) 46-48, Jul, 2011
-
Case Reports in Dermatology, 3(2) 151-154, May, 2011 Peer-reviewed
-
Journal of environmental dermatology and cutaneous allergology, 5(2) 91-102, Apr 30, 2011
-
Journal of environmental dermatology and cutaneous allergology, 5(2) 132-139, Apr 30, 2011
-
Journal of Environmental Dermatology and Cutaneous Allergology, 5(2) 115-123, Apr, 2011
-
JOURNAL OF DERMATOLOGY, 37 90-91, Sep, 2010
-
Journal of environmental dermatology and cutaneous allergology, 4(2) 89-98, Apr 30, 2010
-
Hifu no kagaku, 8(4) 407-415, Aug, 2009A 52-year-old Japanese man presented at our hospital with low-grade fever, swelling on the right side of the chin, and purpura with blood blisters on the four limbs and hip. Based on the high inflammatory reaction shown by laboratory data, he was diagnosed as having Henoch-Schönlein purpura caused by facial cellulitis, and the pathological examination demonstrated leukocytoclastic vasculitis. Antibiotics were effective for cellulitis, but new purpura developed ; therefore, we started prednisolone (20mg/day), which improved his skin condition. Thereafter, he complained of abdominal pain and hematochezia. Because factor XIII activity was 72%, we administered factor XIII concentrate and increased the prednisolone dose to 60mg/day. There was no obvious discharge, so we decreased prednisolone to 40mg/day. He suddenly developed a massive hemorrhage, causing hemorrhagic shock. Pulsed steroid therapy was not effective, but plasmapheresis markedly improved his abdominal condition. Plasmapheresis is a useful tool to treat severe gastrointestinal symptoms of a non-responder to steroid therapy.
-
Journal of environmental dermatology and cutaneous allergology, 2(3) 167-172, Aug 30, 2008
-
Journal of environmental dermatology and cutaneous allergology, 1(1) 43-46, Apr 30, 2007
-
13(1) 186-186, Apr 26, 2002
-
American Journal of Contact Dermatitis, 13(1) 45-46, 2002
-
Environmental dermatology : the official journal of the Japanese Society for Contact Dermatitis, 8 52-32, Nov 1, 2001
-
皮膚, 43(1) 62-66, Feb, 2001症例は35歳女性で右側頭部の有痛性皮疹を主訴とした.オーストラリア旅行中に疼痛を感じ帰国後,近医を受診したが処置されなかった.口周囲のしびれ感が出現したため皮膚科を受診しマダニ咬症と診断された.右側頭部に約6mm大の虫体を認めた.右顔面は軽度の紅斑と主徴を認め,両頸部リンパ節は軽度に腫脹していた.虫体から約2mmm離して周囲の皮膚組織を含めて切除,縫合した.ミノサイクリンを処方したが右顔面の腫脹・紅斑が増強し,右顔面神経麻痺が出現したため入院した.ライム病による紅斑や神経麻痺も否定できずミノサイクリン,アンピシリン等の抗生物質投与を行った.顔面の紅斑,腫脹は数日で軽快した.麻痺症状も1ヵ月で消失した
-
皮膚, 43(1) 19-23, Feb, 200151歳女性.アレルギー性結膜炎のため点眼液を処方されたが,使用時に両眼瞼周囲のかゆみを伴う皮疹が出現した.眼圧が上昇したため使用を中止したが,パッチテストでサジテン点眼液とフサコール点眼液が陽性であり,フマル酸ケトチフェンによるアレルギー性接触皮膚炎と診断した.点眼液の使用を中止させプレドニゾロン眼軟膏を外用し皮疹は数日で消退した
Research Projects
1-
科学研究費助成事業, 日本学術振興会, Apr, 2021 - Mar, 2024